Market News AIOpen the app

KALA BIO, Inc. has been told by Nasdaq that it might be removed from the stock market.

TroubleRead the original at SEC EDGAR
Bad for KALA

Nasdaq let KALA keep its listing for now, but it must meet $1-per-share closing-price tests through February 23, 2027. It had already missed the $1 minimum for 30 business days, and the panel can still reconsider, so losing the listing remains a real risk.

KALA · KALA BIO, Inc.

AI read · Bad for KALA

The AI's read

The permission does not remove KALA's listing problem. KALA still has to meet the required closing-price tests and follow other Nasdaq rules. The panel can reconsider, and KALA says it cannot assure it will comply. Those risks outweigh the temporary permission to stay listed.

Get alerts for KALA

Follow KALA BIO, Inc. (KALA) free. When we publish a story about it, you get the plain-English explanation as an alert.

Get alerts for KALA
Free on the App Store and Google Play, or on the web.